Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg): A Triple‑Pathway Tool for Metabolic & Growth Hormone Research

If your research investigates the complex interplay between lipid metabolism, growth hormone (GH) secretion, and tissue regeneration, the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) offers a sophisticated, multi‑pathway experimental platform. This 12 mg formulation combines three distinct and well‑characterised research peptides—Fragment 176-191 (a lipolytic fragment of human growth hormone), CJC-1295 (a modified GHRH analog), and Ipamorelin (a selective ghrelin receptor agonist)—each acting through complementary mechanisms to modulate metabolic signalling and the GH axis. By targeting the GHRH receptor, the ghrelin receptor, and peripheral lipid metabolism, this blend allows researchers to model the synergistic interplay between these pathways, providing deeper insight into the regulatory circuits that govern metabolic homeostasis, growth hormone pulsatility, and tissue repair.

At Chinese Grey Peptides, we supply high‑purity Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into metabolic regulation, GH signalling, and tissue regeneration begin with uncompromising quality.

What Is the Fragment 176-191 & CJC-1295 & Ipamorelin Blend and How Does It Work?

To fully appreciate the research potential of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg), it is essential to understand the distinct yet complementary mechanisms of its three components. The blend typically contains 6 mg of Fragment 176-191, 3 mg of CJC-1295, and 3 mg of Ipamorelin, though exact ratios may vary by formulation.

Fragment 176-191 (AOD9604): The Lipolytic HGH Fragment

Fragment 176-191, also known as AOD9604, is a synthetic peptide corresponding to the C‑terminal region (residues 176‑191) of human growth hormone (hGH). Unlike full‑length hGH, Fragment 176‑191 selectively targets pathways involved in lipid metabolism without significantly impacting insulin or IGF‑1 levels. The peptide is believed to promote lipolysis (the breakdown of stored fat) while inhibiting lipogenesis (the formation of new fat deposits). It may target beta‑3 adrenergic receptors (ADRB3), potentially inducing weight loss downstream and boosting fat burning in adipose tissue cells. Fragment 176-191 exhibits lipolytic activity similar to that of growth hormone, without the accompanying hyperglycemia. It has a molecular weight of approximately 1,817 Da and a sequence of YLRIVQCRSVEGSCGF.

CJC-1295: The Long‑Acting GHRH Analog

CJC-1295 is a synthetic peptide derivative of growth hormone‑releasing hormone (GHRH). It is a tetrasubstituted form of hGRF(1‑29) that activates the GHRH receptor on the anterior pituitary. Unlike CJC‑1295‑DAC, which contains a drug affinity complex (DAC) moiety and has a half‑life of approximately 6‑8 days, the version in this blend—CJC‑1295 without DAC (also called Modified GRF 1‑29)—does not contain the DAC moiety. However, it still features four specific amino acid substitutions that enhance its stability and resistance to proteolytic degradation, including a D‑alanine substitution at the 2‑position that resists enzymatic degradation by dipeptidylpeptidase‑IV (DPP‑IV).

As a GHRH analogue, CJC‑1295 binds to GHRH receptors on pituitary somatotrophs, stimulating the synthesis and release of growth hormone. The version without DAC creates GH pulses that closely mimic natural physiology, supporting a more pulsatile release pattern. Its molecular weight is approximately 3,367.97 g/mol.

Ipamorelin: The Selective Ghrelin Receptor Agonist

Ipamorelin is a synthetic pentapeptide and a potent, selective agonist of the ghrelin receptor (GHS‑R1a). It was first described in a 1998 paper in the European Journal of Endocrinology as “the first selective growth hormone secretagogue”. Its defining pharmacological advantage is GH stimulation without significantly elevating cortisol, ACTH, or prolactin, even at doses well above those required for GH stimulation. This selectivity distinguishes it from earlier secretagogues like GHRP‑6 and makes it a cleaner tool for studying GH dynamics.

Ipamorelin binds to cells expressing GHS‑R1a with high affinity and induces inositol‑1,4,5‑triphosphate (IP₃) accumulation. Its molecular formula is C₃₈H₄₉N₉O₅, with a molecular weight of approximately 711.8 g/mol.

Mechanism of Synergy: Triple‑Pathway Activation

The scientific rationale for combining Fragment 176-191, CJC‑1295, and Ipamorelin lies in their convergent yet distinct mechanisms:

• Fragment 176‑191 provides a peripheral metabolic signal, promoting lipolysis and inhibiting lipogenesis through pathways that may involve beta‑3 adrenergic receptors.

• CJC‑1295 provides the primary stimulus to initiate GH synthesis and release by activating the classical GHRH receptor pathway.

• Ipamorelin enhances the amplitude of that response by engaging the ghrelin/secretagogue receptor system.

Research demonstrates that this dual‑pathway approach—CJC‑1295 activating the GHRH receptor and Ipamorelin stimulating the ghrelin receptor—produces GH pulses exceeding those of either peptide alone. GHRH + GHRP combinations produce GH release greater than the sum of either agent alone, with studies demonstrating synergistic GH output. This triple‑pathway activation has been suggested by researchers to potentially synergistically enhance and regulate growth hormone concentration and maintain equilibrium levels.

Key Research Applications for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

The Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is a versatile tool with applications spanning several domains of metabolic and endocrine research.

1. Metabolic & Lipid Research

Fragment 176‑191’s ability to stimulate lipolysis and inhibit lipogenesis makes this blend a valuable tool for studying lipid metabolism. Research applications include:

• Lipolysis Signalling Pathways: Investigating the molecular mechanisms that trigger the breakdown of triglycerides in adipocytes, including the beta‑3 adrenergic receptor‑cAMP‑PKA‑HSL cascade

• Adipocyte Metabolism: Studying the regulation of lipid storage and mobilisation in adipose tissue

• Metabolic Homeostasis: Exploring how modulation of lipid metabolism affects overall metabolic equilibrium

• Fat Oxidation Pathways: Investigating the peptide’s potential to impact energy expenditure and fat oxidation pathways

2. Growth Hormone Axis & Pituitary Function Studies

The CJC‑1295 and Ipamorelin components provide a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• Synergistic GH Secretion: The effects of combined GHRH and ghrelin receptor activation on GH synthesis and pulsatile release

• Receptor Pharmacology: The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion

• Pulsatile Dynamics: The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation

• Hypothalamic‑Pituitary Function: Coordinated growth hormone axis modelling

3. Tissue Repair & Regeneration Research

Fragment 176‑191 has been hypothesised to impact cellular repair and regeneration processes, particularly in tissues affected by injury or degeneration. Research applications include:

• Cartilage Repair: Research suggests AOD9604 may enhance cartilage regeneration in models of knee osteoarthritis

• Collagen Synthesis: Studying the peptide’s potential to support collagen synthesis and extracellular matrix remodelling

• Bone Remodelling: Investigating pathways involved in bone formation and resorption, with potential support for the mineralisation of bone

4. Oncology Research

A 2022 study published in Drug Design, Development and Therapy demonstrated that Fragment 176‑191 enhances the toxicity of doxorubicin‑loaded chitosan nanoparticles against MCF‑7 breast cancer cells. Research applications include:

• Targeted Drug Delivery: Investigating the use of Fragment 176‑191 to enhance tumour drug accumulation

• Anticancer Efficacy: Studying the peptide’s ability to enhance the anti‑proliferative activity of chemotherapeutic agents

5. Body Composition & Recovery Research

The blend is hypothesised to address both sides of the body composition equation simultaneously:

• Fat Reduction: Through Fragment 176‑191’s direct lipolytic activity

• Muscle Preservation: Through CJC‑1295 and Ipamorelin’s GH‑mediated anabolic signalling

• Recovery Enhancement: Studying how enhanced GH secretion supports tissue repair and recovery

Chemical & Physical Specifications for Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Accurate characterisation of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is essential for reproducible experimental design.

Note: The 12 mg mass represents the total peptide weight of the blend (6 mg Fragment 176‑191, 3 mg CJC‑1295, and 3 mg Ipamorelin). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety.

Reconstitution & Handling Protocol for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Proper reconstitution of the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is critical for maintaining the structural integrity and biological activity of all three peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 12 mg per 1.2 mL of diluent, yielding a 10 mg/mL total peptide concentration.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table for Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is 6 mg Fragment 176‑191, 3 mg CJC‑1295, and 3 mg Ipamorelin per 12 mg vial.

Storage & Stability Guidelines for Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Why Choose Chinese Grey Peptides for the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)?

As an authentic licensed peptide supplier based in the USA, we supply the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO). This peptide blend is intended strictly for laboratory research, analytical, or reference use, where permitted by local regulations. Not for human or veterinary use.

Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

What is the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)?
It is a research‑grade formulation combining Fragment 176‑191 (AOD9604, a lipolytic HGH fragment), CJC‑1295 (a modified GHRH analog without DAC), and Ipamorelin (a selective ghrelin receptor agonist). It is used as a triple‑pathway tool to study metabolic regulation, lipid metabolism, and growth hormone signalling.

 How does each component work?
Fragment 176‑191 promotes lipolysis and inhibits lipogenesis, potentially through beta‑3 adrenergic receptors. CJC‑1295 binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release. Ipamorelin binds to the growth hormone secretagogue receptor (GHS‑R1a), amplifying GH release without elevating cortisol, ACTH, or prolactin.

What is the composition of the 12 mg blend?
The blend contains 6 mg of Fragment 176-191, 3 mg of CJC-1295 (without DAC), and 3 mg of Ipamorelin in a single lyophilised vial.

What purity does your Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) meet?
Each component is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

 How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

 What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (as in this blend) does not contain a drug affinity complex moiety and has a shorter half‑life than the DAC‑conjugated version. The version without DAC supports a more pulsatile release pattern that may better replicate the natural secretion of growth hormone.

 Is this peptide blend legal to purchase in the USA for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: These peptides are not FDA‑approved for human use and are banned by the World Anti‑Doping Agency (WADA) for athletic use.

Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

https://www.ncbi.nlm.nih.gov

https://pubmed.ncbi.nlm.nih.gov

• https://google.com

• https://medium.com

• https://quora.com

• https://pinterest.com

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

• 1. Shop Page
  2. Bulk Orders Page
  3. Contact Page
  4. Shipping & Return Page
  5. Quality Documentation Page
  • PubChem NAD+ / Nadide
  • NCBI Bookshelf NAD overview
  • PubChem NADH
  • FDA label claims for foods and dietary supplements
  • FDA structure/function claims guidance
  • Google Merchant Center structured data guidance
  • Rank Math WooCommerce Product Schema

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Ships to USA, Canada, UK & Europe

Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.

Shipping support may include:

• Order processing updates
• Packaging support
• Tracking information where available
• Wholesale shipment planning
• Destination-based shipping review
• Customer support during transit

Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Why Choose Chinese Grey Peptides?

Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.

Customers choose us for:

• Professional peptide and specialty product support
• Small and wholesale order options
• Product documentation support
• COA review where available
• HPLC testing information where available
• International shipping support
• Responsive communication
• Clear order assistance before payment

We aim to make the buying process transparent, professional, and documentation-focused.

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

Important Compliance Notice

FOXO4-DRI (10mg) may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, IV guidance, anti-aging claims, energy claims, longevity claims, detox claims, mitochondrial claims, disease claims, treatment claims, or personal-use recommendations.

Customers are responsible for understanding and following all local laws, import rules, supplement rules, prescription requirements, compounding rules, labeling rules, advertising rules, and permitted-use requirements before ordering.

Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)

From its innovative design as a triple‑pathway metabolic and GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between lipid metabolism, GHRH, and ghrelin receptor activation, the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) provides a uniquely versatile platform for advanced metabolic and endocrinological research.

Its ability to stimulate lipolysis, promote GH release through both GHRH and ghrelin pathways, and support tissue regeneration—supported by peer‑reviewed research published in the Journal of Endocrinology and other authoritative journals—makes it a valuable addition to any laboratory investigating metabolic regulation, lipid metabolism, or the GH/IGF‑1 axis. By choosing high‑purity, lab‑verified Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the USA, UK, or Europe.